very day, patients and their physicians confront decisions without the evidence they need to inform the choice. Absent this evidence, guidelines are replete with recommendations that rely on expert opinion because needed studies are absent (1) . Moreover, even when there is high-grade clinical trial evidence, the reported efficacy in idealized settings may not necessarily reflect what can be achieved in actual practice. As a result, interest in developing evidence that flows from the experience of clinical practice is growing. In fact, the concept of the learning health care system derives from the notion that data produced in the course of clinical care can be transformed into practical evidence about what comparative strategies can achieve under typical clinical conditions (2) .
Two primary strategies can be applied in typical clinical settings to provide evidence on effectiveness. One strategy, the pragmatic clinical trial, applies an experimental design within routine practice settings (3) . There is continued interest in these trials, but the pace of knowledge production is slow and the expense is relatively high. The other strategy is to leverage observational data and variation in practice patterns to produce meaningful comparisons of alternative strategies. This approach can produce new evidence faster and more efficiently, but questions about the validity of the findings have limited their impact. An important issue is whether comparative effectiveness research using observational data can be strong enough to influence practice.
In this issue, Hansen and colleagues provide a good case study for the dilemma of comparative effectiveness research using observational data (4). The investigators sought to determine whether an early invasive strategy (defined as coronary angiography within 72 hours) was superior to a more conservative strategy (defined as delayed or no angiography) for patients hospitalized for an acute coronary syndrome. They leveraged national administrative databases and the adoption in 2009 of compulsory protocols requiring diagnostic coronary angiography for these patients within 72 hours of hospitalization, and they used advanced methods to address selection bias. The authors reported that the early invasive strategy achieved remarkably better outcomes than the conservative strategy.
The study seeks to draw a causal inference between the use of an invasive strategy and the better outcomes. However, the design severely limits the capacity of the study to support such an inference. At best, it provides no evidence to impugn the belief that the early invasive therapy is better.
There are many threats to the validity of the causal inference in this study. First, as noted by the authors, they lacked clinical data on the patients, including electrocardiographic findings, cardiac troponin measurements, Global Registry of Acute Coronary Events scores, and left ventricular ejection fraction. They also lacked information about the indication for the procedure, which is particularly important given prior work that has compared routine invasive strategies (applied to everyone) with selective invasive strategies (reserved for persons who develop symptoms despite optimal medical therapy) (5) . Evaluating the success of the propensity score matching for these key clinical data, which are measurable but missing, is therefore impossible. In addition, judgments about referrals for procedures may take into account frailty, dementia, and other functional disabilities that are poorly documented in the chart. The inclusion of patients with unstable angina, the unreliability of the codes, and the possibility that the procedure and its outcome could influence the coding are also of concern. Finally, there is a key temporal issue: The invasive strategy was compulsory in the later years of the study, which is particularly important for a condition that in most countries is trending toward improved outcomes over time.
Another important issue is that the validity of the comparison requires that patients in both groups be considered candidates for either strategy (6) . This study considered all patients who did not undergo angiography to be in the comparison group, but there is no evidence that they all were candidates for an early invasive therapy.
The predicament is that this study-comparative effectiveness research that used national observational data, applied strong analytic methods, and was published in a leading journal-cannot strongly support causal inference. The quality of the data remains a critical issue, as do the questions about whether the methods can overcome concerns about residual confounding. Almost every article resulting from a comparative effectiveness study using observational data, however well-done, must be circumspect in asserting causal inference.
Moreover, even if the results were valid, the perceived weaknesses undermine the influence of the contribution. Many observational studies agree with trial results, but some do not (7) . According to guideline standards, the observational data provide grade "B" evidence at best. Furthermore, that classification of strength of evidence does not even consider the quality of the data used.
All of this raises a reasonable question: Should we conduct these studies given their very limited ability to influence guidelines and practice? In addition, can we develop methods that provide greater confidence in the ability of studies using observational data to guide practice? Given that the comparative effectiveness of complex interventions may be influenced not only by This article was published online first at www.annals.org on 27 October 2015.
Annals of Internal Medicine
EDITORIAL the relative efficacy of the strategies but also by the multiplicity of factors involved in their application in practice, it is also critical that this research isolate implementation factors contributing to the results and the way that they might affect the translation of the results in other settings.
Much work remains before comparative effectiveness studies using observational data become meaningful for influencing clinical practice, including improving the quality of data, strengthening analytic methods with attention to assessing comparative effects and modifying factors, and reaching consensus on validation approaches (8, 9) . Meanwhile, these studies remain interesting yet fall short in altering our assessments of the comparative performance of each strategy.
